First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

1. García Alfonso, P.
2. Valladares-Ayerbes, M.
3. Muñoz Luengo, J.
4. Pimentel, P.
5. Viéitez, J.M.
6. Cruz Hernandez, J.J.
7. Llanos, M.
8. Garcia Girón, C.
9. Salud Salvia, A.
10. Lloansí Vila, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDY281.092 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus